Clinical Trials Browser

Phase 3 × Terminated × ibritumomab tiuxetan × Clear all

NCT00322218 2022-01-19

Study Comparing Zevalin Regimen With no Further Treatment in Patients With Diffuse Large B-cell Lymphoma.

Phase 3 Terminated

68 enrolled 9 charts

Lymphoma, Large B-Cell, Diffuse

NCT01510184 2021-12-16

Study of Zevalin Versus Observation in Participants at Least 60 Years Old With Newly Diagnosed Diffuse Large B-cell Lymphoma in Positron Emission Tomography (PET)-Negative Complete Remission After Rituximab-Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone (R-CHOP) or R-CHOP-like Therapy

Phase 3 Terminated

79 enrolled 9 charts

Lymphoma, Follicular, Lymphoma, Large B-Cell, Diffuse

NCT01662102 2021-10-04

Rituximab or Zevalin - Efficacy Trial of Therapeutic Alternatives (RoZetta)

Phase 3 Terminated

1 enrolled 1 chart

Lymphoma, Follicular

NCT02366663 2018-03-12

SPINOZA

Phase 3 Terminated

3 enrolled 8 charts

Immune System Diseases, Immunoproliferative Disorders, Lymphatic Diseases, Lymphoma, Lymphoma, Non-Hodgkin, Lymphoproliferative Disorders, Neoplasms, Neoplasms by Histologic Type, Lymphoma, B-Cell, Lymphoma, Large B-Cell, Diffuse

NCT00057343 2006-09-12

Safety and Efficacy of Zevalin in the Treatment of Non-Hodgkin's Lymphoma

Phase 3 Terminated

Lymphoma, Non-Hodgkin